Sinopharm considering $1B buy for Shanghai-based DNA maker BBI Life Sciences: report - FierceBiotech

Submitted by Anonymous (not verified) on Fri, 07/08/2022 - 14:49

Sinopharm considering $1B buy for Shanghai-based DNA maker BBI Life Sciences: report  FierceBiotech